PRMT1 and malignant colon neoplasm: With the RIP3ADMA antibody, we were able to characterize the protein levels of RIP3 R486 methylation together with PRMT1 in the colon adenocarcinoma tissue chip containing the colon cancer samples from 93 patients (Table S1).